Dublin, April 13, 2022 (GLOBE NEWSWIRE) -- The "Injectable Devices for Subcutaneous Self-administration to 2028" report has been added to ResearchAndMarkets.com's offering. Because of the ongoing ...

Octapharma USA today announced the U.S. Food & Drug Administration has approved cutaquig [Immune globulin, Subcutaneous (Human)-hipp, 16.5% Solution] for the treatment of pediatric patients age 2 ...

DUBLIN-- (BUSINESS WIRE)--The "Injectable Devices for Subcutaneous Self-administration to 2028" report has been added to ResearchAndMarkets.com's offering.Because of the ongoing need for repeat dosing ...

KORU Medical Systems develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world.

Researchers reported calculated geometric mean ratios comparing subcutaneous vs. intravenous administration for C trough of 1.15 (90% CI, 1.04-1.26) for C2D1 and 1.43 (90% CI, 1.27-1.61) for C4D1.

Dublin, April 01, 2025 (GLOBE NEWSWIRE) -- The "Subcutaneous Biologics Market, Industry Trends and Global Forecasts to 2035: Type of Biologic, Type of Therapy, Method of Administration ...

These results, with the KORU Freedom Infusion System, also demonstrate the company’s potential to support a broader range of developmental subcutaneous drug therapies.” About KORU Medical Systems ...

Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients --The world's first and only wearable, disposable ...

Compared with oral administration, continuous subcutaneous infusion of carbidopa/levodopa was linked to nearly 2 more hours of “on” time without dyskinesia in adults with Parkinson’s disease ...

A Biologics License Application has been filed with the Food and Drug Administration (FDA) for subcutaneous treatment with the bispecific monoclonal antibody Rybrevant (amivantamab-vmjw) and the ...

Tyenne is supplied as a 20mg/mL single-dose vial (80mg/4mL, 200mg/10mL, or 400mg/20mL) for further dilution prior to IV infusion.

Dublin, April 01, 2025 (GLOBE NEWSWIRE) -- The "Subcutaneous Biologics Market, Industry Trends and Global Forecasts to 2035: Type of Biologic, Type of Therapy, Method of Administration, Fundamental ...